During the past decade, Cebu Cancer Institute; Perpetual Succour Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cebu Cancer Institute; Perpetual Succour Hospital" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cebu Cancer Institute; Perpetual Succour Hospital" are "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Cebu Cancer Institute; Perpetual Succour Hospital" in a lesser frequency.

Most popular intervention types in "Cebu Cancer Institute; Perpetual Succour Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials), "Trastuzumab" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cebu Cancer Institute; Perpetual Succour Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cebu Cancer Institute; Perpetual Succour Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cebu Cancer Institute; Perpetual Succour Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cebu Cancer Institute; Perpetual Succour Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".